Spedra (Avanafil)

Spedra is a pharmaceutical product primarily used to treat erectile dysfunction. The active ingredient, avanafil, was initially developed by a Japanese pharmaceutical company and later licensed for international distribution. In Europe and other global markets, the brand has seen various licensing agreements to ensure broad clinical availability.

The medication is frequently manufactured in Italy under strict pharmaceutical quality standards before being distributed to various pharmacies worldwide. Ownership and licensing rights are held by Menarini Group, a prominent Italian multinational pharmaceutical company, which acquired rights from the original developer to commercialize the product across multiple territories.